PRMT1 and esophageal squamous cell carcinoma: PRMT1 was also responsible for promoting the Wnt and Notch pathways in ESCC, leading to increased tumour initiating cells with enhanced self-renewal capabilities and resistance to cisplatin treatment (Zhao et al., 2019).